ENGLISH ABSTRACT
JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
REVIEW
Add like
Add dislike
Add to saved papers

[Treatment of insulin-dependent diabetes: new therapeutics. Cellular replacement: facts and perspectives].

The replacement of insulin producing beta cells by islet transplantation can effectively control blood glucose levels in individuals with Type I diabetes. Recent improvements in clinical results were made possible by transplantation of greater islet masses and introduction of new immunosuppressive protocols, which avoid diabetogenicity. Future, widespread clinical application of islet transplantation will depend on the availability of an unlimited source of glucose sensitive, insulin-secreting tissue and less toxic immunosuppressors.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app